west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "心内直视" 25 results
  • Efficacy of Radiofrequency Modified Maze Procedure Combined with Open-heart Surgery for Atrial Fibrillation

    Objective To evaluate the efficacy of Radiofrequency (RF) modified maze procedure combined with open-heart surgery for atrial fibrillation (AF). Methods From January 2003 to October 2004, 66 patients underwent the RF modified maze Ⅲ procedure for AF combined with open-heart surgery. The preoperative and postoperative indexes of electrocardiogram and echoeardiogram were compared through retrospective analysis and follow-up. Postoperative cardiac function and thromboembolie events were evaluated through telephone and mail. Results The time needed for RF modified maze Ⅲ was 18.61±3.56 min. There were no hospital deaths and the complications was 15.15%(10/66). Follow-up duration was 14.25±6.47 months with 95.45%(63/66) completion. At the lastest follow-up, the rate of freedom from AF was 80.95% (51/63)and the rate of restoration to sinus rhythm was 74.60%(47/63). No thromboembolic events was seen. 77.78%(49/63) of patients were in NYHA class Ⅰ. Significant decrease was seen in both left atrial dimension (LAD) and left ventricular dimension (LVD)(P〈0.01) more than 6 months after operation. Conclusion RF modified maze Ⅲ procedure as an adjunctive procedure is safe, time-sparing and effective in eliminating AF.

    Release date:2016-08-30 06:23 Export PDF Favorites Scan
  • 新型心脏停搏液灌注器在心肌保护中的应用

    目的报告新型心脏停搏液灌注器在心肌保护中的应用。方法100例心脏病患者在心内直视术中采用自行设计制造的高钾温-冷-温血心脏停搏液灌注器和新的高钾氧合血配备方法进行心肌保护。结果体外循环时间31~163min,平均52.5min,主动脉阻断时间11~112min,平均42.6min,心脏自动复跳率100%,均为窦性心律。结论自行设计的新型心脏停搏液灌注器和新的高钾氧合血配备方法在心内直视手术中的心肌保护效果确切、满意,有一定的临床应用价值。

    Release date:2016-08-30 06:26 Export PDF Favorites Scan
  • Clinical Application of Combined Treatment with Probiotics and Lactulose after Open Heart Surgery under Cardiopulmonary Bypass: A Control Study

    Objectives To investigate the effect of the combined treatment with probiotics and lactulose of gastrointestinal function and postoperative infection after open cardiac surgery. Methods We retrospectively analyzed the clinical data of 264 patients underwent cardiopulmonary bypass in our hospital between August 2013 and June 2014. There were 129 males and 135 females at the mean age of 53.06±10.97 years. We divided those patients into a treatment group and a control group. In the treatment group, there were 58 males and 63 females at the mean age of 52.29±14.31 years. They took probiotics and lactulose from the first day to the seventh day after operation. In the control group, there were 71 males and 72 females at the mean age of 52.29±14.31 years. They didn’t take probiotics or lactulose after the surgery. Procalcitonin (PCT) and lipopolysaccharides (LPS) concentrations were measured before operation, at 24 hours postoperatively, at 72 hours and on the seventh day. We recorded the condition of postoperative infection, gastrointestinal disorders and relative informations. Results The PCT and LPS concentrations in the treatment group after 72 hours postoperatively were statistically lower than those of the control group (1.04±5.39 ng/ml vs. 3.51±4.28 ng/ml, P=0.04; 11.28±4.34 EU/ml vs. 21.59±7.34 EU/ml, P=0.03). The PCT and LPS concentrations in the treatment group were also statistically lower than those of the control group on the 7th day postoperatively (0.17±2.79 ng/ml vs. 1.98±4.62 ng/ml,P=0.04; 6.74±6.38 EU/ml vs. 15.96±4.61 EU/ml, P=0.01). The ICU stay time (43.25±14.36 h vs. 63.47±24.46 h, P=0.01) and postoperative hospital stay time (15.07±4.52 d vs. 21.08±6.49 d, P=0.02) were significantly less in the treatment group than those in the control group. The morbidity of infection and the morbidity of gastrointestinal disorders of the treatment group were statistically less than those of the control group (1.65% vs. 5.59%, P=0.00; 2.48% vs. 6.99%, P<0.001), and there was no statistical difference in mortality between the two groups (1.65% vs. 2.10%, P=0.12). Conclusions The combined treatment with probiotics and lactulose can improve the postoperative inflammatory reaction, gastrointestinal function, and reduce the morbidity of infection.

    Release date: Export PDF Favorites Scan
  • 胸骨正中小切口在心脏直视手术中的应用

    目的 介绍胸骨正中小切口在心脏手术中的应用效果. 方法 风湿性心瓣膜病或先天性心脏病患者40例,分别在常规体外循环或常温心脏不停跳下行心内直视术.做胸骨下端正中小切口,长5~9cm,保留胸骨柄的连续性. 结果 手术均顺利进行,术后无严重并发症发生,循环稳定,恢复快,瘢痕隐蔽.心脏不停跳手术患者,术后辅助呼吸和使用正性肌力药物的时间明显缩短. 结论 胸骨正中小切口可以安全的应用于多种常规和心脏不停跳心内直视手术,适应范围广、创伤小、手术效果好和美容效果佳.

    Release date:2016-08-30 06:31 Export PDF Favorites Scan
  • 心内直视手术中鱼精蛋白毒性反应的发生及处理

    目的 分析心内直视手术中鱼精蛋白毒性反应发生情况、临床特点,探讨处理措施。 方法 2001年1月~2006年1月,连续行1 163例心内直视手术中发生鱼精蛋白毒性反应31例,其中轻度反应(血压下降lt;30mmHg)26例,中度、重度反应(中度反应血压下降30~49mmHg,重度反应血压下降≥50mmHg)5例;低血压型28例,过敏反应/类过敏反应型2例,肺血管收缩型1例。所有患者均给予立即停止使用鱼精蛋白或减慢鱼精蛋白泵入速度、补充血容量、抗过敏、血管活性药物或再次体外循环治疗。 结果 26例出现轻度鱼精蛋白毒性反应者经停止使用或减慢鱼精蛋白泵入速度及相应治疗后,均很快好转;5例出现中度、重度鱼精蛋白毒性反应者,经停止使用鱼精蛋白、抗过敏、补充血容量、血管活性药物和再次体外循环支持, 4例好转,1例死亡。27例门诊随访3个月,恢复正常学习和工作。 结论 心内直视手术中鱼精蛋白毒性反应发生率高,中度、重度反应者死亡率高。鱼精蛋白毒性反应的发生与其用量和使用方法密切有关,充分认识鱼精蛋白毒性反应的临床特点,精确鱼精蛋白用量和改进使用方法能在一定程度上防治毒性反应的发生。

    Release date:2016-08-30 06:15 Export PDF Favorites Scan
  • Nursing Experiences of Invasive Blood Pressure Monitoring for Patients Having Undergone Open-heart Surgery

    Release date: Export PDF Favorites Scan
  • 婴幼儿与成人体外循环管理比较

    目的 为了婴幼儿心内直视手术顺利进行,探讨其体外循环(ECC)的特点。方法 对近3年来施行的59例10kg以下婴幼儿ECC进行总结,并与同期205例成人ECC进行比较。结果 婴幼儿组死亡5例,成人组死亡5例。两组术中均未发生ECC意外和与其相关的并发症。其中成人组在转流时间、阻断时间、预充液用量、钾用量、碳酸氢钠用量、库血用量、转流中尿量等方面明显高于婴幼儿组(P<0.05和P<0.01);而转流中流量和使用库血例数则较婴幼儿组明显减少(P<0.01),整个ECC期间婴幼儿组血气改变较大,特别是在转流20分钟时较明显(P<0.05);两组对血钾的影响差别无显著性意义。结论 对婴幼儿ECC应采用高流量灌注,应用高质量膜肺,并注意心肌保护,酸碱平衡和电解质平衡,预充液应选择不含糖溶液。

    Release date:2016-08-30 06:33 Export PDF Favorites Scan
  • 7262例体外循环管理经验总结

    目的总结体外循环(CPB)管理的经验及教训,为更安全的CPB方式提供参考。方法回顾性分析我院1964年2月~2004年12月施行的CPB心内直视手术7262例患者的临床资料,并对硬件设备、转流技术、灌注师经验、术中监测及心肌保护等方面进行分析,其中3748例患者采用心脏不停跳CPB。结果全组死亡248例,总死亡率3.4%(248/7262)。1964年2月~1983年12月施行CPB手术464例,死亡52例,死亡率11.2%;1984年1月~1996年12月施行CPB手术1709例,死亡78例,死亡率4.6%;1997年1月~2004年12月施行CPB手术5089例,死亡118例,死亡率2.3%;1997年3月~2004年12月,对3748例患者采用心脏不停跳CPB,手术顺利,未发生与CPg相关的并发症及死亡。结论灌注师的经验和硬件设备的完善、使用高质量的人工心肺机和氧合器、多种转流技术的应用、完善的监测系统等可明显提高CPB的安全性。心脏不停跳下CPB是安全且易于管理的一种方式。

    Release date:2016-08-30 06:18 Export PDF Favorites Scan
  • 心脏手术后床边二次开胸止血94例

    目的总结体外循环心脏手术后床边二次开胸止血的经验,并分析出血的原因,以减少心脏手术后出血并发症的发生率。方法回顾性分析94例心脏手术后床边二次开胸止血患者的临床资料,其中先天性心脏病矫治术47例,心瓣膜置换术36例,冠状动脉旁路移植术5例,大血管病手术4例,心脏肿瘤摘除术2例。结果床边二次开胸见胸腔广泛渗血或心包腔、胸腔积血27例次,主动脉出血25例次,心脏出血24例次.胸骨出血18例次,其他原因引起的出血16例次。床边二次开胸止血术后死亡12例(12.77%),死亡原因为心搏骤停、呼吸衰竭、低心排血量和多器官功能衰竭等。术后伤口感染12例(12.77%)。结论术中严格止血是减少术后二次开胸止血的关键,减少二次开胸手术可降低患者的死亡率和伤口感染的发生率。

    Release date:2016-08-30 06:26 Export PDF Favorites Scan
  • 先天性心脏病心脏不停跳心内直视手术

    摘要 目的 介绍体外循环心脏不停跳下心内直视手术治疗先天性心脏病心内畸形的应用体会。 方法 327例先天性心脏病心内畸形行浅低温体外循环心脏不停跳心内直视手术。常规建立体外循环,置左心房引流管,降温至32±1℃并维持,仅阻断上、下腔静脉,不阻断升主动脉,维持灌注压在60mmHg左右,在心脏不停跳下施行心脏畸形矫正术,方法同心脏停搏手术。 结果 死亡7例,死亡率2.1%,其余均痊愈出院,随访1~13个月,恢复良好。 结论 心脏不停跳下心内直视手术有较好的心肌保护作用,能减少并发症的发生,并简化操作,缩短体外循环时间。

    Release date:2016-08-30 06:33 Export PDF Favorites Scan
3 pages Previous 1 2 3 Next

Format

Content